TITLE:
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension

CONDITION:
Open-Angle Glaucoma

INTERVENTION:
Brimonidine Tartrate Ophthalmic Solution

SUMMARY:

      The primary objective of this study is to compare the safety and efficacy of Brimonidine
      Tartrate Ophthalmic Solution, 0.15% in patients with open-angle glaucoma or ocular
      hypertension.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 2 Months to N/A
Criteria:

        -  Patients of any race

          -  two (2) years of age or older

          -  of either sex

          -  diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment
             dispersion component)or ocular hypertension
      
